Company Number: 13131975

Analysis Date: 2025-07-20 17:45 UTC

1. Credit Opinion: APPROVE
   Choose Therapy Ltd demonstrates a positive financial trajectory with improving net assets and working capital over the last three years. The company maintains a solid micro-entity balance sheet with increasing equity, indicating sound financial stewardship by management. There are no red flags such as overdue filings or insolvency proceedings, and the director has taken responsibility for compliance. The company’s ability to meet short-term liabilities is strong, supporting debt servicing and operational liquidity.

2. Financial Strength:
   The balance sheet shows steady growth in net assets from £2,575 in 2021 to £28,081 in 2024. Fixed assets are minimal but immaterial given the service nature of the business (human health activities). Current assets more than doubled from £22,926 in 2023 to £44,272 in 2024, while current liabilities increased modestly to £16,715, resulting in net current assets of £27,557. Shareholders’ funds fully cover liabilities, reflecting a conservative capital structure without reliance on external debt.

3. Cash Flow Assessment:
   The company’s working capital position is healthy, with current assets comfortably exceeding current liabilities. This suggests adequate liquidity to cover operational expenses and short-term obligations. The increase in net current assets year-on-year points to improving cash flow management, which is critical for a micro-entity in a service industry. Although no cash flow statement is provided, the balance sheet indicators imply no immediate liquidity concerns.

4. Monitoring Points:

• Continue tracking net current assets and net assets to ensure ongoing improvement or stability.
• Monitor cash flow generation and receivables turnover, especially as revenues grow.
• Watch for any increase in short-term liabilities that may pressure liquidity.
• Review director and PSC changes or any adverse filings that may impact governance or credit risk.